We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Clorox Company (CLX - Free Report) reported fourth-quarter fiscal 2017 results, wherein adjusted earnings from continuing operations of $1.53 per share rose 21% year over year and also beat the Zacks Consensus Estimate of $1.49.
The company expects earnings for fiscal 2018 to be in the range of $5.52–$5.72 per share, reflecting a growth 3%–7%.
Earnings Estimate Revision: The Zacks Consensus Estimate for the current fiscal has been trending down in the last 30 days. If we look at Clorox’s performance in the trailing four quarters (excluding the quarter under review), the company has underperformed the Zacks Consensus Estimate by an average of 0.6%.
Revenues: Clorox generated net sales of $1,647 million that climbed 2.9% year over year beating the Zacks Consensus Estimate of $1,640.9 million. The year over year increase was backed by solid volume growth, contributions from the RenewLife business and improved prices in the International division, partially offset by unfavorable mix.
The company anticipates sales growth of 2%–4% for fiscal 2018. Sales in fiscal 2018 are expected to gain from strong innovation and price increases, partially offset by currency headwinds.
Check back later for our full write up on Clorox’s earnings report!
More Stock News: Tech Opportunity Worth $386 Billion in 2017
From driverless cars to artificial intelligence, we've seen an unsurpassed growth of high-tech products in recent months. Yesterday's science-fiction is becoming today's reality. Despite all the innovation, there is a single component no tech company can survive without. Demand for this critical device will reach $387 billion this year alone, and it's likely to grow even faster in the future.
Zacks has released a brand-new Special Report to help you take advantage of this exciting investment opportunity. Most importantly, it reveals 4 stocks with massive profit potential.
Image: Bigstock
Clorox (CLX) Tops Q4 Earnings & Sales, Initiates FY18 View
The Clorox Company (CLX - Free Report) reported fourth-quarter fiscal 2017 results, wherein adjusted earnings from continuing operations of $1.53 per share rose 21% year over year and also beat the Zacks Consensus Estimate of $1.49.
The company expects earnings for fiscal 2018 to be in the range of $5.52–$5.72 per share, reflecting a growth 3%–7%.
Earnings Estimate Revision: The Zacks Consensus Estimate for the current fiscal has been trending down in the last 30 days. If we look at Clorox’s performance in the trailing four quarters (excluding the quarter under review), the company has underperformed the Zacks Consensus Estimate by an average of 0.6%.
Clorox Company (The) Price and EPS Surprise
Clorox Company (The) Price and EPS Surprise | Clorox Company (The) Quote
Revenues: Clorox generated net sales of $1,647 million that climbed 2.9% year over year beating the Zacks Consensus Estimate of $1,640.9 million. The year over year increase was backed by solid volume growth, contributions from the RenewLife business and improved prices in the International division, partially offset by unfavorable mix.
The company anticipates sales growth of 2%–4% for fiscal 2018. Sales in fiscal 2018 are expected to gain from strong innovation and price increases, partially offset by currency headwinds.
Zacks Rank: Currently, Clorox carries a Zacks Rank #3 (Hold) which is subject to change following the earnings announcement. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Check back later for our full write up on Clorox’s earnings report!
More Stock News: Tech Opportunity Worth $386 Billion in 2017
From driverless cars to artificial intelligence, we've seen an unsurpassed growth of high-tech products in recent months. Yesterday's science-fiction is becoming today's reality. Despite all the innovation, there is a single component no tech company can survive without. Demand for this critical device will reach $387 billion this year alone, and it's likely to grow even faster in the future.
Zacks has released a brand-new Special Report to help you take advantage of this exciting investment opportunity. Most importantly, it reveals 4 stocks with massive profit potential.
See these stocks now>>